We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The platform features inhaler sensors designed to automatically capture patient monitoring data, such as “when and how well patients use their medication,” Amiko said. Read More
The assays are intended to provide improved sensitivity for clinical assessments of patients’ response to tyrosine kinase inhibitor therapies. Read More
The technology offers an “extended depth-of-focus design to address known optical risk factors associated with myopia progression,” the company said. Read More